Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$2.61 -0.16 (-5.96%)
At close: Oct 1, 2026 · 4:00 PM EDT

Zentalis Pharmaceuticals (ZNTL) Preferred Stock Liabilities (2019 - 2020)

Updated

Zentalis Pharmaceuticals (ZNTL) recorded Preferred Stock Liabilities of $155.93 million in Q1 2020, up 10.0% from the prior quarter.

Analysis

Zentalis Pharmaceuticals (ZNTL) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

At the end of FY2019, Zentalis Pharmaceuticals reported Preferred Stock Liabilities of $141.71 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Zentalis Pharmaceuticals 198.52 Mn 198.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 155.93 Mn
Dec 31, 2019 141.71 Mn
Sep 30, 2019 141.71 Mn
API Access

Zentalis Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ZNTL&period=max&api_key=YOUR_API_KEY